GSK gets positive EU opinion for respiratory syncytial virus vaccine
GSK PLC on Thursday said its respiratory syncytial virus vaccine candidate has gained positive opinion from the European Medicines Agency body. The Brentford, London-based pharmaceutical firm said... | April 27, 2023